MDM2 and infection: LY6E has been shown to specifically impair SARS-CoV-2 entry, and—given the similarity of the infection phenotype in our live-cell imaging screen (Supplementary Figure S1B,C)—we speculated that MDM2 might be involved in virus uptake.